183 related articles for article (PubMed ID: 16431998)
1. Serum concentrations of C reactive protein, alpha1 antitrypsin, and complement (C3, C4, C1 esterase inhibitor) before and during the Vuelta a Espańa.
Semple SJ; Smith LL; McKune AJ; Hoyos J; Mokgethwa B; San Juan AF; Lucia A; Wadee AA
Br J Sports Med; 2006 Feb; 40(2):124-7. PubMed ID: 16431998
[TBL] [Abstract][Full Text] [Related]
2. Changes in mucosal and humoral atopic-related markers and immunoglobulins in elite cyclists participating in the Vuelta a España.
McKune AJ; Smith LL; Semple SJ; Wadee AA; Fickl H; Villa JG; Gómez-Gallego F; San Juan AF; Lucia A
Int J Sports Med; 2006 Jul; 27(7):560-6. PubMed ID: 16802252
[TBL] [Abstract][Full Text] [Related]
3. Relation between physical exertion and heart rate variability characteristics in professional cyclists during the Tour of Spain.
Earnest CP; Jurca R; Church TS; Chicharro JL; Hoyos J; Lucia A
Br J Sports Med; 2004 Oct; 38(5):568-75. PubMed ID: 15388541
[TBL] [Abstract][Full Text] [Related]
4. alpha1-acid glycoprotein and alpha1-antitrypsin as early markers of treatment response in patients receiving the intensive phase of tuberculosis therapy.
Almeida ML; Barbieri MA; Gurgel RQ; Abdurrahman ST; Baba UA; Hart CA; Shenkin A; Silva AM; de Souza L; Cuevas LE
Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):575-80. PubMed ID: 19211120
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes, complement factors C3, C4, C1-inhibitor, alpha-1-antitrypsin and immunoglobulins in asthmatic patients.
Häfner GE; Wüthrich B; Grob PJ; Arrenbrecht S
Respiration; 1981; 41(4):248-57. PubMed ID: 6975491
[TBL] [Abstract][Full Text] [Related]
6. [Fibronectin and other immunologic parameters in chronic polyarthritis].
Siegmeth W; Minar E; Graninger W; Pirich K; Zazgornik J
Z Rheumatol; 1984; 43(1):27-9. PubMed ID: 6201023
[TBL] [Abstract][Full Text] [Related]
7. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
Thielmann M; Marggraf G; Neuhäuser M; Forkel J; Herold U; Kamler M; Massoudy P; Jakob H
Eur J Cardiothorac Surg; 2006 Aug; 30(2):285-93. PubMed ID: 16829095
[TBL] [Abstract][Full Text] [Related]
8. Effect of interferon-gamma on complement gene expression in different cell types.
Lappin DF; Guc D; Hill A; McShane T; Whaley K
Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):437-42. PubMed ID: 1531292
[TBL] [Abstract][Full Text] [Related]
9. Tour de France versus Vuelta a España: which is harder?
Lucia A; Hoyos J; Santalla A; Earnest C; Chicharro JL
Med Sci Sports Exerc; 2003 May; 35(5):872-8. PubMed ID: 12750600
[TBL] [Abstract][Full Text] [Related]
10. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
Ziccardi RJ
J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
[TBL] [Abstract][Full Text] [Related]
11. Serum alpha1-antitrypsin but not complement C3 and C4 predicts chronic inflammation in hemodialysis patients.
Borawski J; Naumnik B; Myśliwiec M
Ren Fail; 2003 Jul; 25(4):589-93. PubMed ID: 12911163
[TBL] [Abstract][Full Text] [Related]
12. C1-esterase inhibitor infusion increases survival rates for patients with sepsis*.
Igonin AA; Protsenko DN; Galstyan GM; Vlasenko AV; Khachatryan NN; Nekhaev IV; Shlyapnikov SA; Lazareva NB; Herscu P
Crit Care Med; 2012 Mar; 40(3):770-7. PubMed ID: 22080632
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of immunoglobulins and complement components in patients with recurrence after resection of gastric carcinoma.
Janssen CW; Tønder O; Matre R
Cancer Detect Prev; 1987; 10(3-4):303-9. PubMed ID: 3568028
[TBL] [Abstract][Full Text] [Related]
14. High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitis.
Bene L; Füst G; Fekete B; Kovács A; Horváth L; Prohászka Z; Miklós K; Pálos G; Daha M; Farkas H; Varga L
Dig Dis Sci; 2003 Jun; 48(6):1186-92. PubMed ID: 12822883
[TBL] [Abstract][Full Text] [Related]
15. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events.
Palikhe A; Sinisalo J; Seppänen M; Haario H; Meri S; Valtonen V; Nieminen MS; Lokki ML
Am J Cardiol; 2007 Apr; 99(7):890-5. PubMed ID: 17398178
[TBL] [Abstract][Full Text] [Related]
16. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.
Pinckard RN; Olson MS; Giclas PC; Terry R; Boyer JT; O'Rourke RA
J Clin Invest; 1975 Sep; 56(3):740-50. PubMed ID: 808560
[TBL] [Abstract][Full Text] [Related]
17. Protease inhibitors in plasma of patients with chronic urticaria.
Doeglas HM; Bleumink E
Arch Dermatol; 1975 Aug; 111(8):979-85. PubMed ID: 60915
[TBL] [Abstract][Full Text] [Related]
18. [Does the assay of acute phase protein concentrations in cerebrospinal fluid and/or in serum in patient with viral meningitis have a diagnostic value? Part II. Lymphocytic meningitis caused by echo 30 virus].
Mamełka B; Lobos M; Sass-Just M; Dworniak D; Urbaniak A; Terlecka M; Paradowski M
Przegl Epidemiol; 2004; 58(2):351-9. PubMed ID: 15517816
[TBL] [Abstract][Full Text] [Related]
19. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).
Windfuhr JP; Alsenz J; Loos M
Mol Immunol; 2005 Apr; 42(6):657-63. PubMed ID: 15781109
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein and natural IgM antibodies are activators of complement in a rat model of intestinal ischemia and reperfusion.
Padilla ND; van Vliet AK; Schoots IG; Valls Seron M; Maas MA; Peltenburg EE; de Vries A; Niessen HW; Hack CE; van Gulik TM
Surgery; 2007 Nov; 142(5):722-33. PubMed ID: 17981193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
